Scholarly Debate About Drug Efficacy in Scientific Journals Is "Protected Speech," Not Libel.
Publication
, Other
Kharasch, ED; Klaas, PB; Lanier, WL
Published in: Mayo Clin Proc
February 2024
Duke Scholars
Published In
Mayo Clin Proc
DOI
EISSN
1942-5546
Publication Date
February 2024
Volume
99
Issue
2
Start / End Page
198 / 202
Location
England
Related Subject Headings
- Speech
- Publishing
- Periodicals as Topic
- Humans
- 32 Biomedical and clinical sciences
- 11 Medical and Health Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Kharasch, E. D., Klaas, P. B., & Lanier, W. L. (2024). Scholarly Debate About Drug Efficacy in Scientific Journals Is "Protected Speech," Not Libel. Mayo Clin Proc. England. https://doi.org/10.1016/j.mayocp.2023.12.003
Kharasch, Evan D., Paul B. Klaas, and William L. Lanier. “Scholarly Debate About Drug Efficacy in Scientific Journals Is "Protected Speech," Not Libel.” Mayo Clin Proc, February 2024. https://doi.org/10.1016/j.mayocp.2023.12.003.
Kharasch ED, Klaas PB, Lanier WL. Scholarly Debate About Drug Efficacy in Scientific Journals Is "Protected Speech," Not Libel. Vol. 99, Mayo Clin Proc. 2024. p. 198–202.
Kharasch, Evan D., et al. “Scholarly Debate About Drug Efficacy in Scientific Journals Is "Protected Speech," Not Libel.” Mayo Clin Proc, vol. 99, no. 2, Feb. 2024, pp. 198–202. Pubmed, doi:10.1016/j.mayocp.2023.12.003.
Kharasch ED, Klaas PB, Lanier WL. Scholarly Debate About Drug Efficacy in Scientific Journals Is "Protected Speech," Not Libel. Mayo Clin Proc. 2024. p. 198–202.
Published In
Mayo Clin Proc
DOI
EISSN
1942-5546
Publication Date
February 2024
Volume
99
Issue
2
Start / End Page
198 / 202
Location
England
Related Subject Headings
- Speech
- Publishing
- Periodicals as Topic
- Humans
- 32 Biomedical and clinical sciences
- 11 Medical and Health Sciences